Hiroki Sato, Wataru Ichikawa, Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, Yoshihiro Kakeji, Masahiro Takeuchi, Yu Sunakawa, Masashi Fujii, Takeshi Sano. "Individualized estimation of benefit from adjuvant docetaxel plus S-1 in stage III gastric cancer using deep learning–based counterfactual survival analysis of the START-2 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4095